Risk of hepatocellular carcinoma in antiviral treatment-naïve chronic hepatitis B patients treated with entecavir or tenofovir disoproxil fumarate: a network meta-analysis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Risk of hepatocellular carcinoma in antiviral treatment-naïve chronic hepatitis B patients treated with entecavir or tenofovir disoproxil fumarate: a network meta-analysis
Authors
Keywords
-
Journal
BMC CANCER
Volume 22, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-03-18
DOI
10.1186/s12885-022-09413-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lower risk of hepatocellular carcinoma with tenofovir than entecavir treatment in subsets of chronic hepatitis B patients: an updated meta‐analysis
- (2022) Bao‐Hong Yuan et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- No difference in hepatocellular carcinoma risk in chronic hepatitis B patients treated with tenofovir vs entecavir: evidence from an updated meta-analysis
- (2021) Jie Yuan et al. Aging-US
- Validation of the HCC‐RESCUE score to predict hepatocellular carcinoma risk in Caucasian chronic hepatitis B patients under entecavir or tenofovir therapy
- (2021) Fatih Güzelbulut et al. JOURNAL OF VIRAL HEPATITIS
- No Difference in Incidence of Hepatocellular Carcinoma in Patients With Chronic HBV Infection Treated With Entecavir vs Tenofovir
- (2020) Hyunwoo Oh et al. Clinical Gastroenterology and Hepatology
- Tenofovir versus entecavir in lowering the risk of hepatocellular carcinoma development in patients with chronic hepatitis B: a critical systematic review and meta-analysis
- (2020) Min Li et al. Hepatology International
- Effects of Tenofovir vs Entecavir on Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection: A Systematic Review and Meta-analysis
- (2020) Won-Mook Choi et al. Clinical Gastroenterology and Hepatology
- Comparative Effectiveness of Entecavir vs Tenofovir for Preventing Hepatocellular Carcinoma in Patients with Chronic Hepatitis B: a Systematic Review and Meta-analysis
- (2020) Shravan Dave et al. HEPATOLOGY
- Incidence and predictors of hepatocellular carcinoma beyond year 5 of entecavir therapy in chronic hepatitis B patients
- (2020) Fai-Meng Sou et al. Hepatology International
- Comparison of the on‐treatment risks for hepatocellular carcinoma between entecavir and tenofovir: A propensity score matching analysis
- (2020) Ingyoon Ha et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Comparison of TDF versus ETV on reducing incidence of hepatocellular carcinoma in chronic hepatitis B patients: A Systematic Review and Meta‐Analysis
- (2020) Lihu Gu et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Magnitude of and prediction for risk of hepatocellular carcinoma in patients with chronic hepatitis B taking entecavir or tenofovir therapy: A systematic review
- (2020) Cheng‐Hao Tseng et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Tenofovir Treatment Has Lower Risk of Hepatocellular Carcinoma than Entecavir Treatment in Patients with Chronic Hepatitis B: A Systematic Review and Meta-Analysis
- (2020) Hairong Liu et al. Liver Cancer
- High Level of Medication Adherence Is Required to Lower Mortality in Patients with Chronic Hepatitis B Taking Entecavir: A Nationwide Cohort Study
- (2020) Jayoun Lee et al. JOURNAL OF VIRAL HEPATITIS
- Hepatocellular carcinoma incidence with tenofovir versus entecavir in chronic hepatitis B: a systematic review and meta-analysis
- (2020) Cheng-Hao Tseng et al. Lancet Gastroenterology & Hepatology
- The effectiveness of TDF versus ETV on incidence of HCC in CHB patients: a meta analysis
- (2019) Zeyu Zhang et al. BMC CANCER
- A multi-center study of entecavir vs. tenofovir on prognosis of treatment-naïve chronic hepatitis B in the Republic of Korea
- (2019) Seung Up Kim et al. JOURNAL OF HEPATOLOGY
- Notice of Retraction and Replacement. Choi et al. Risk of hepatocellular carcinoma in patients treated with entecavir vs tenofovir for chronic hepatitis B: a Korean nationwide cohort study. JAMA Oncol. 2019;5(1):30-36
- (2019) Young-Suk Lim et al. JAMA Oncology
- Nucleos(t)ide Analogues for Reducing Hepatocellular Carcinoma in Chronic Hepatitis B Patients: A Systematic Review and Meta-Analysis
- (2019) Xinhui Wang et al. Gut and Liver
- Tenofovir is Associated With Lower Risk of Hepatocellular Carcinoma Than Entecavir in Patients With Chronic HBV Infection in China
- (2019) Terry Cheuk-Fung Yip et al. GASTROENTEROLOGY
- Tenofovir Versus Entecavir for Hepatocellular Carcinoma Prevention in an International Consortium of Chronic Hepatitis B
- (2019) Yao-Chun Hsu et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Comparison of tenofovir and entecavir on the risk of hepatocellular carcinoma and mortality in treatment-naïve patients with chronic hepatitis B in Korea: a large-scale, propensity score analysis
- (2019) Sung Won Lee et al. GUT
- Tenofovir may be superior to entecavir for preventing hepatocellular carcinoma and mortality in individuals chronically infected with HBV: a meta-analysis
- (2019) Yu-Xian Teng et al. GUT
- Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
- (2018) Norah A. Terrault et al. HEPATOLOGY
- Remaining hepatocellular carcinoma risk in chronic hepatitis B patients receiving entecavir/tenofovir in South Korea
- (2018) Jung Hwan Yu et al. HEPATOLOGY RESEARCH
- Clinical utility of hepatitis B surface antigen kinetics in treatment-naïve chronic hepatitis B patients during long-term entecavir therapy
- (2018) Tien-Ching Lin et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Risk of Hepatocellular Carcinoma in Patients Treated With Entecavir vs Tenofovir for Chronic Hepatitis B
- (2018) Jonggi Choi et al. JAMA Oncology
- Serum M2BPGi level and risk of hepatocellular carcinoma after oral anti-viral therapy in patients with chronic hepatitis B
- (2018) Yao-Chun Hsu et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
- (2017) Pietro Lampertico et al. JOURNAL OF HEPATOLOGY
- Higher risk of hepatocellular carcinoma in chronic hepatitis B vs chronic hepatitis C after achievement of virologic response
- (2017) G.-A. Kim et al. JOURNAL OF VIRAL HEPATITIS
- Effects of antiviral therapy in patients with chronic hepatitis B and cirrhosis
- (2017) Masako Okada et al. Expert Review of Gastroenterology & Hepatology
- The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level
- (2017) et al. JAMA Oncology
- Rapid Alanine Aminotransferase Normalization with Entecavir and Hepatocellular Carcinoma in Hepatitis B Virus-Associated Cirrhosis
- (2016) Eui Joo Kim et al. DIGESTIVE DISEASES AND SCIENCES
- Low-level viremia and the increased risk of hepatocellular carcinoma in patients receiving entecavir treatment
- (2016) Jung Hee Kim et al. HEPATOLOGY
- Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients
- (2016) Tung-Hung Su et al. LIVER INTERNATIONAL
- Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
- (2015) S. K. Sarin et al. Hepatology International
- Risk of hepatocellular carcinoma in chronic hepatitis B: Assessment and modification with current antiviral therapy
- (2015) George V. Papatheodoridis et al. JOURNAL OF HEPATOLOGY
- The incidence of hepatocellular carcinoma is reduced in patients with chronic hepatitis B on long-term nucleos(t)ide analogue therapy
- (2014) C. S. Coffin et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Seven-Year Efficacy and Safety of Treatment with Tenofovir Disoproxil Fumarate for Chronic Hepatitis B Virus Infection
- (2014) Maria Buti et al. DIGESTIVE DISEASES AND SCIENCES
- Mortality, Liver Transplantation, and Hepatocellular Carcinoma Among Patients With Chronic Hepatitis B Treated With Entecavir vs Lamivudine
- (2014) Young–Suk Lim et al. GASTROENTEROLOGY
- Meta-analysis: the impact of oral anti-viral agents on the incidence of hepatocellular carcinoma in chronic hepatitis B
- (2013) A. K. Singal et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection
- (2012) Tetsuya Hosaka et al. HEPATOLOGY
- Network meta-analysis, electrical networks and graph theory
- (2012) Gerta Rücker Research Synthesis Methods
- Comparison of the Efficacy of Entecavir and Tenofovir in Chronic Hepatitis B
- (2011) Fatih Güzelbulut et al. HEPATO-GASTROENTEROLOGY
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
- (2010) Andreas Stang EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B
- (2010) Ting-Tsung Chang et al. HEPATOLOGY
- Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: A systematic review
- (2010) George V. Papatheodoridis et al. JOURNAL OF HEPATOLOGY
- Network meta-analysis: simultaneous meta-analysis of common antiplatelet regimens after transient ischaemic attack or stroke
- (2008) V. Thijs et al. EUROPEAN HEART JOURNAL
- Natural history of hepatitis-related hepatocellular carcinoma
- (2008) David-Yiu-Kuen But WORLD JOURNAL OF GASTROENTEROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started